metformin and 4-iodo-6-phenylpyrimidine

metformin has been researched along with 4-iodo-6-phenylpyrimidine in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Belfiore, A; Beznoussenko, GV; Bongarzone, I; Bozzi, F; Caccia, C; Gariboldi, M; Gloghini, A; Leo, E; Leoni, V; Manenti, G; Milione, M; Mironov, AA; Mogavero, A; Pierotti, MA; Pilotti, S; Varinelli, L; Volpi, CC	1

Other Studies

1 other study(ies) available for metformin and 4-iodo-6-phenylpyrimidine

Article	Year
MIF/CD74 axis is a target for novel therapies in colon carcinomatosis. Journal of experimental & clinical cancer research : CR, 2017, 01-23, Volume: 36, Issue:1 Topics: AMP-Activated Protein Kinases; Antigens, Differentiation, B-Lymphocyte; Cell Proliferation; Cell Survival; Colonic Neoplasms; Energy Metabolism; Histocompatibility Antigens Class II; Humans; Intramolecular Oxidoreductases; Macrophage Migration-Inhibitory Factors; Metformin; Molecular Targeted Therapy; Peritoneal Neoplasms; Proteomics; Pyrimidines; Receptors, G-Protein-Coupled; Signal Transduction; Tumor Cells, Cultured	2017

Article

Year

MIF/CD74 axis is a target for novel therapies in colon carcinomatosis.

Journal of experimental & clinical cancer research : CR, 2017, 01-23, Volume: 36, Issue:1

Topics: AMP-Activated Protein Kinases; Antigens, Differentiation, B-Lymphocyte; Cell Proliferation; Cell Survival; Colonic Neoplasms; Energy Metabolism; Histocompatibility Antigens Class II; Humans; Intramolecular Oxidoreductases; Macrophage Migration-Inhibitory Factors; Metformin; Molecular Targeted Therapy; Peritoneal Neoplasms; Proteomics; Pyrimidines; Receptors, G-Protein-Coupled; Signal Transduction; Tumor Cells, Cultured

2017